In this State of Nation Report: No Cancer Too Rare, Cancer52 reviews policy developments since the 2024 General Election that will shape the next 10 years of cancer services. The report also reflects on what these developments means for our priorities for the UK Government and for making rare and less common cancers a priority in national policy.

Cancer52’s newest member, The Bardo Foundation is an international childhood cancer charity founded in memory of Bernardo “Bardo” Eggesbø.

Leiomyosarcoma Research UK has joined Cancer52.

The Rare Cancers Act 2026 will prioritise long overlooked aspects of research, and has the potential to transform outcomes for those affected by rare and less common cancers.

MOVE Against Cancer has joined Cancer52! Their mission is to support and empower everyone impacted by cancer to be more active because movement matters. They deliver evidence-based support through 5k Your Way community groups, tailored online programmes and accessible resources, improving wellbeing and supporting health outcomes during and after treatment. 

In a breakthrough moment, the Government has made a clear commitment to focus specifically on rare and less common cancers within a national cancer strategy. A full chapter of the plan is dedicated to these cancers, which is an important step forward that recognises their unique challenges. Their prominence in the National Cancer Plan for England is a credit to the tireless efforts of our cancer charity members and the wider rare and less common cancer community.

Cancer52 is delighted to welcome The Get A-Head Charitable Trust as our newest member!

Cancer52 has submitted a response to the call for evidence to shape the National Cancer Plan for England

Cancer52 has released its latest report on health inequalities , as part of the Big Cancer52 Conversation event. >> Read report...

Fair Market Value (FMV) Guidance is now available to bring consistency to reimbursement for cross-sector partnership work. See FMV...